EugeneR.ViscusiMD
Anesthesiology • Philadelphia, PAPain Medicine
Associate Professor, Anesthesiology, Jefferson Medical College-Thos Jefferson Univ
Dr. Viscusi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 S 11th St
Suite 8490
Philadelphia, PA 19107Phone+1 215-955-6161Fax+1 215-923-5507
Summary
- Dr. Eugene Viscusi is an anesthesiologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Jefferson Medical College and has been in practice 36 years. He specializes in pain medicine. He is president of ASRA (The American Society of Regional Anesthesia and Pain Medicine) 2019-2021
Education & Training
University of Pennsylvania Health SystemResidency, Anesthesiology, 1982 - 1984
Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 1981 - 1982
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981, MD
Certifications & Licensure
NJ State Medical License 1984 - Present
PA State Medical License 1982 - 2024- PA State Medical License 1984 - 2024
- American Board of Anesthesiology Anesthesiology
Clinical Trials
- Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients Start of enrollment: 2008 Jan 01
- A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery Start of enrollment: 2002 May 01
Publications & Presentations
PubMed
- 23 citationsEvaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trialNarinder Rawal, Eugene R. Viscusi, Paul M. Peloso, Harold S. Minkowitz, Liang Chen
BMC Musculoskeletal Disorders. 2013-10-24 - 156 citationsA randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain.Eugene R. Viscusi, Lynn R. Webster, Michael E. Kuss, Stephen E. Daniels, James A. Bolognese
Pain. 2016-01-01 - 14 citationsKetamine in the Past, Present, and Future: Mechanisms, Metabolites, and ToxicityEric S. Schwenk, Basant Pradhan, Rohit Nalamasu, Lucas Stolle, Irving W. Wainer
Current Pain and Headache Reports. 2021-07-16
Press Mentions
Screen All Patients for Cannabis Use Before Surgery: GuidelineJanuary 9th, 2023- Kowa Pharmaceuticals America,Inc. Announces Publication of Phase 3 Data Supporting FDA Approval of SEGLENTIS®(Celecoxib 56-Mg and Tramadol Hydrochloride 44mg)CI-v as an Efficacious Alternative for Moderate-to-Severe Acute Pain in Appropriate PatientsJuly 19th, 2022
Introduction: How Should the Joint Surgeon Respond to the Opioid Crisis?August 13th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
